Scientific Papers. Each Party through is Alliance Manager shall provide to the other, prior to submission of a draft of any articles and papers, including primary reports of Data, pooled analyses, theses, dissertations and review papers concerning a CoDev Product, which have been prepared by or on behalf of such Party or under a CoDev Product Plan (each a “Scientific Paper”) to be published in medical and scientific journals and similar publications (“Medical Journals”). Commencing with the receipt of such draft Scientific Paper, the receiving Party shall have [***] Business Days to notify the sending Party of its observations and suggestions with respect thereto (it being understood that, during such [***] Business Day period, no submission for publication thereof shall take place) and the Parties shall discuss these observations and suggestions. The receiving Party shall have the right to require modifications to such Scientific Paper to remove the Confidential Information of the receiving Party if so requested by the receiving Party. The Party proposing to publish such Scientific Paper shall, in good faith, consider the comments made by the other Party, particularly if disclosure may be prejudicial to the other Party’s opportunity to obtain any Patent. The other Party may in good faith require that the publication be suspended for a period of time not exceeding [***] days if a Patent may be filed using the Data or other Know-How covered in the proposed publication, which period could be extended to an additional [***] month period with respect to Data or other Know-How useful to enrich the Patent applications provided that in the event such additional delay is requested, (a) such requesting Party must reasonably demonstrate the need for such extension by providing the other Party with a detailed rationale and explanation therefore along with a reasonably detailed work plan as to how such delay and experiments may improve patentability and (b) the Parties will discuss in good faith the scope and duration of any such extended delay (not to exceed such [***] months). Neither Party will publish or present any Confidential Information of the other Party without such other Party’s prior written consent. The sending Party shall provide to the receiving Party a copy of each final Scientific Paper published by a Medical Journal within [***] Business Days of publication thereof. 110 Portions of the exhibit, indicated by the xxxx “[***],” were omitted and have been filed separately ...
Scientific Papers. The performer shall publish scientific papers in accordance with the Attachment No. Statement of Work. One (1) copy of each published scientific paper shall be submitted via email or otherwise provided to the DARPA Agreements Officer’s Representative, DARPA Program Manager, and DARPA Agreements Officer. Scientific Papers shall be marked with Distribution Statement A: Enclosure 1 Conformed Copy P00011 Agreement No. HR0011-12-3-0006 Attachment 2 "Approved for public release; distribution is unlimited.”
Scientific Papers. Each Party through a JPT shall provide to the other, prior to submission of any Scientific Paper to a Medical Journal, a draft of such Scientific Paper. Commencing with the receipt of such draft Scientific Paper, the receiving Party shall have [*] Business Days to notify the sending Party of its observations and suggestions with respect thereto; it being understood that, during such [*] Business Day period, no submission for publication thereof shall take place and the Parties shall discuss these suggestions. The Party proposing to publish such Scientific Paper shall, in good faith, consider the comments made by the other Party, particularly if disclosure may be prejudicial to the other Party’s opportunity to obtain any patent rights. A Party will not publish or present any Confidential Information of the other Party without such other Party’s prior written consent. The sending Party shall provide to the receiving Party copies of any final Scientific Paper accepted by a Medical Journal, not less than [*] Business Days or as soon as practicable prior to the planned publication thereof (upon availability and distribution of such information assuming that providing such information is acceptable taking into consideration the publishers’ need to comply with any healthcare compliance guidelines). To enable free exchange of copyrighted material between the Parties, each Party agrees that it has or shall (i) obtain and maintain, at its own expense, an Annual Copyright License or equivalent license from the Copyright Clearance Center and (ii) list the other Party as a collaborator in an agreement with the Copyright Clearance Center.
Scientific Papers. Without prejudice of the provisions set forth in Section 10.4, each Party through the JSC or its designee shall provide to the other, prior to submission for publication, of a draft of any articles and papers containing Confidential Information or concerning the Product which have been prepared by or on behalf of such Party in the Field (each a “Scientific Paper”) to be published in indexed medical and scientific journals and similar publications (“Medical Journals”). Commencing with the receipt of such draft Scientific Paper, the receiving Party shall have fifteen (15) business days to notify the sending Party of its observations and suggestions with respect thereto (it being understood that, during such fifteen (15)-Business Day period, no submission for publication thereof shall take place) and the Parties shall discuss these observations and suggestions. The Party proposing to publish such Scientific Paper shall, in good faith, consider the comments made by the other Party, particularly if disclosure may be prejudicial to the other Party’s opportunity to obtain any Patent. Neither Party will publish or present any Confidential Information of the other Party without such other Party’s prior written consent. The sending Party shall provide to the receiving Party copies of any final Scientific Paper accepted by a Medical Journal, within ten (10) business days after the approval thereof (upon availability and distribution of such information assuming that providing such information is acceptable taking into consideration the publishers’ need to comply with any healthcare compliance guidelines).
Scientific Papers. ALRT and PARI shall work together concerning any materials that are to be published that relate to the Products or the Intellectual Property Rights.
Scientific Papers. Throughout the project, the CompBioMed consortium will publish numerous scientific, peer- reviewed papers, conference proceedings, and chapters in books. Such publications will contain the following passage: “This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 675451.”
Scientific Papers. Throughout the XxX, the CompBioMed consortium will publish numerous scientific, peer- reviewed papers, conference proceedings, and chapters in books. Such publications will contain the following passage: “This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 823712.” We will publish in a variety of high-impact journals across the domains in the XxX. Targets include domain journals such as the Nature Group, Journal of Chemical Theory and Computation, Journal of Medical Chemistry, PLoS (Public Library of Science), Computational Biology, e-Life, Proceedings of the National Academy of Sciences, Heart Rhythm, American Journal of Physiology, Circulation, Frontiers in Physiology, Journal of the Royal Society Interface, Computers in Biology and Medicine, Journal of Physiology or more general computational science / HPC journals such as the Journal of Computational Science, Journal of Uncertainty Quantification, the Journal of Supercomputing, Supercomputing Frontiers and Innovations. All publications will be made open access, at either Green or Gold level. Gold open access is where an author publishes their article in an online open access journal, often paying to unlock open access in a journal (CompBioMed2 has funds for this purpose, held by each partner). In contrast, green open access is where an author publishes their article (often a preprint version) in any journal and then self-archives a copy in a freely accessible institutional or specialist online archive known as a repository, or on a website.
Scientific Papers. The target set for this project is to publish a minimum of 4 papers in scientific journals during the time of its development. For all participants on the Horizon 2020 program, it is necessary to meet a number of requirements related to the diffusion of any result of the project. These include ensuring open access to all peer-reviewed scientific publications, and trying to provide open access to other types of publications, such as monographs, books, reports, etc. For this reason, in the case of any participant that wants to publish a paper under a scientific journal, the procedure to follow will be as explained below: The corresponding authors will be in charge of the selection of the scientific journal to publish their work. This journal will necessarily have to offer an Open Access option for the publication of selected articles. The publication of the work will preferably be made under a ‘Green Open Access’ policy, which will allow any user to access the work after the embargo period of the journal has ended. Embargo periods are different depending on the journals, but this period won’t be able to exceed 6 months for any publication. It is the responsibility of the author to find a journal that fulfils these characteristics. In the case of an article being published in a journal with longer embargo periods, the partners involved shall cover the ‘Gold Open Access’ fee to the publication.
Scientific Papers. On and after the License Effective Date, each Party, through the Publications Committee, shall provide to the other, with at least […***…] notice to the other Party prior to submission of any Scientific Paper primarily related to the use of a Licensed Product as a monotherapy (a “Monotherapy Scientific Paper”) to a Medical Journal, a draft of such Scientific Paper. Commencing with the receipt of such draft Monotherapy Scientific Paper, the receiving Party shall have […***…] to notify the sending Party of its observations and suggestions with respect thereto; it being understood that, during such […***…] period, no submission for publication thereof shall take place and the Parties shall discuss these suggestions if requested by either Party. The Party proposing to publish such Monotherapy Scientific Paper shall, in good faith, consider the comments made by the other Party, and will not publish if disclosure would be prejudicial to the other Party’s opportunity to obtain any patent rights. On and after the License Effective Date, neither Party will publish or present any Confidential Information of the other Party (whether in a Monotherapy Scientific Paper or otherwise) without such other Party’s prior written consent, not to be unreasonably withheld or delayed. The sending Party shall provide to the receiving Party copies of any final Scientific Paper (including any Scientific Paper that is not a Monotherapy Scientific Paper) accepted by a Medical Journal, not less than […***…] or as soon as practicable prior to the planned publication thereof (upon availability and distribution of such information).
Scientific Papers. A detailed list of all the publications (published, in the process of revision, submitted, and in preparation for their submission) will be made available on the website. As agreed among the EUPHORIC consortium, all the scientific partners that have cooperated and have been actively involved in the specific study will appear as authors in these papers. In any case, the list of authors will end "on behalf of the EUPHORIC working group" and the names of the participants in the working group will be listed in the acknowledgements.
